VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RLAY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RLAYRelay Therapeutics, Inc.
$18.60$3.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRLAYQuarterly Cash Flow

Relay Therapeutics, Inc. (RLAY) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Relay Therapeutics, Inc. (RLAY) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

RLAY Cash Flow Statement

Quarterly statement

RLAY Cash Flow Statement

Relay Therapeutics, Inc. (RLAY) cash flow statement — 8-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-63.93M-54.11M-51.11M-44.87M-62.12M-55.26M-73.21M-57.87M-75.08M-65.83M-50.32M-89.19M-75.4M-68.6M-67.13M-57.08M-66.14M-57.09M-49.17M-39.71M
Operating CF Margin %--15459.71%-1703.73%-640.93%--8162.63%-953.38%----502.88%8918800%-299.17%-57647.9%-29703.54%-22560.87%-19228.2%-15641.92%-11735.8%-7003%
Operating CF Growth %-2.92%2.08%30.18%22.47%17.27%16.06%-45.48%35.12%0.42%4.03%25.04%-56.25%-13.99%-20.16%-36.52%-43.75%-24.34%-102.89%-205.43%-12.57%
Net Income-81.75M-83.71M-73.29M-54.89M-74.15M-70.38M-77.06M-76M-88.11M-92.21M-81.39M-83.5M-65.73M-98.5M-94.24M-67.5M-84.17M-76.79M-62.05M-67.46M
Depreciation & Amortization280K360K504K599K748K1M1.21M1.33M1.37M1.37M1.4M1.38M1.36M1.33M1.2M1.17M1.03M956K975K1.03M
Stock-Based Compensation10.12M9.18M10.54M13.07M15.53M14.5M19.32M17.64M22.48M26.83M27.19M19.27M21.84M23.41M21.52M13.82M13.72M15.15M13.46M10.22M
Deferred Taxes000000000005.08M-2.88M0000000
Other Non-Cash Items2.09M-624K-782K-822K-748K1.52M-1.6M-2.28M9.99M-14.66M-5.5M-10.81M-1.2M-4.35M-3.02M-10.93M3.6M746K-3.91M1.52M
Working Capital Changes5.32M20.68M11.92M-2.82M-3.5M-1.91M-15.08M1.45M-20.82M12.84M7.98M-20.6M-28.79M9.51M7.41M6.37M-327K2.85M2.36M14.98M
Change in Receivables00000000000211K-133K5.15M-12K-65K-65K-106K-6K115K
Change in Inventory0000000000021.7M-27.79M0000000
Change in Payables3.95M-3.67M3.67M-6.53M-507K-953K-3.45M11.26M-4.3M3.21M7.64M-5.37M-1.22M2.8M1.4M1.97M4.63M-3.39M-1.22M2.43M
Cash from Investing62.37M-353.03M32.9M35.46M39.73M75.15M42.47M29M-126.16M45.55M10.53M59.68M71.36M51.28M75.31M-146.94M27.19M43.39M-112.38M-292.75M
Capital Expenditures000-1K1K-26K-384K0-227K-11K-1.78M-118K-590K-1.5M-1.92M-2.32M-2.1M-1.86M-2.79M-880K
CapEx % of Revenue---0.01%-3.84%5%---17.79%-11800%2.34%1263.03%847.35%915.41%609.01%508.77%666.83%155.2%
Acquisitions00000000000-257.63M-71.95M000000-83K
Investments--------------------
Other Investing00000000000257.63M71.95M0000000
Cash from Financing4.42M323.74M138.78M934K17K653K0800K218.89M1.54M48.92M21.92M9.46M2.08M1.3M1.17M285.87M2M883K384.01M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)4.42M323.74M138.78M934K17K653K0800K218.16M1.54M47.73M20.92M9.36M2.08M1.3M1.17M02M883K382.21M
Dividends Paid00000000000000000000
Share Repurchases00000653K00000000000000
Other Financing00000000732K01.19M1M95K000285.87M001.8M
Net Change in Cash2.86M-83.4M120.57M-8.47M-22.38M20.54M-30.75M-28.07M17.64M-18.74M9.13M-7.59M5.43M-15.37M9.48M-202.85M246.91M-11.71M-160.67M51.56M
Free Cash Flow-63.93M-54.11M-51.11M-44.87M-62.12M-55.29M-73.59M-57.87M-75.31M-65.84M-52.1M-89.31M-75.99M-70.1M-69.05M-59.4M-68.24M-58.95M-51.97M-40.59M
FCF Margin %--15459.71%-1703.73%-640.94%--8166.47%-958.38%----520.67%8930600%-301.51%-58910.92%-30550.88%-23476.28%-19837.21%-16150.68%-12402.63%-7158.2%
FCF Growth %-2.92%2.13%30.55%22.47%17.52%16.03%-41.25%35.2%0.89%6.08%24.54%-50.36%-11.35%-18.92%-32.86%-46.34%-24.22%-106.7%-212.57%-14.86%
FCF per Share-0.29-0.27-0.28-0.26-0.36-0.32-0.43-0.35-0.54-0.50-0.40-0.73-0.62-0.58-0.57-0.49-0.62-0.54-0.48-0.40
FCF Conversion (FCF/Net Income)0.78x0.65x0.70x0.82x0.84x0.79x0.95x0.76x0.85x0.71x0.62x1.07x1.15x0.70x0.71x0.85x0.79x0.74x0.79x0.59x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000